SCHEMBL5367750

SCHEMBL5367750

COc1cc(N(C)C)ccc1C=C1C(=O)Nc2ccc(CCCl)cc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 8/20 0.56
PSEN1 P49768 2/20 0.52
PSEN2 P49810 2/20 0.52
APH1B Q8WW43 2/20 0.52
NCSTN Q92542 2/20 0.52
APH1A Q96BI3 2/20 0.52
PSENEN Q9NZ42 2/20 0.52
NPC1 O15118 1/20 0.45
MAPT P10636 4/20 0.44
APP P05067 2/20 0.44
SNCA P37840 1/20 0.44
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
FLT3 P36888 1/20 0.42
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SRC P12931 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5364261 0.86 MDM2 (0.55) MDM2PSEN1PSEN2APH1BNCSTN
SCHEMBL5361384 0.85 MDM2 (0.54) MDM2PSEN1PSEN2APH1BNCSTN
SCHEMBL7135678 0.84 NPC1 (0.65) MDM2PSEN1PSEN2APH1BNCSTN
SCHEMBL5368871 0.82 KMT2A (0.53) MDM2PSEN1PSEN2APH1BNCSTN
SCHEMBL5373793 0.82 MAPT (0.66) MDM2PSEN1PSEN2APH1BNCSTN
SCHEMBL5362547 0.82 MAPT (0.65) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5357633 0.80 CSNK1D (0.64) MDM2PSEN1PSEN2APH1BNCSTN
SCHEMBL5373291 0.80 MDM2 (0.55) MDM2NPC1MAPTCCNE1CDK2
SCHEMBL5359526 0.79 NPC1 (0.51) MDM2PSEN1PSEN2APH1BNCSTN
SCHEMBL5368833 0.78 PLK4 (0.60) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK MDM2 888/4885PSEN1 3695/4885PSEN2 3641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.